A retrospective cohort study of pimavanserin in a older adults with parkinson's disease
Latest Information Update: 20 Aug 2021
At a glance
- Drugs Pimavanserin (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
Most Recent Events
- 13 Aug 2021 Results published in the Neurology
- 14 Jun 2021 New trial record
- 15 May 2021 Results presented at the 2021 Annual Scientific Meeting of the American Geriatrics Society.